QuantumCyte

Extract maximum information from every tissue sample

By connecting image-based annotation and molecular testing via an integrated system, QCPRECISE™ is the missing piece of your end-to-end precision diagnostics workflow.

Delivers high cellular purity for genomics, transcriptomics, and proteomics—even from small, complex, and low tumor-content biopsies.

Enables end-to-end precision at scale with automated, high-throughput processing.

Connects AI-powered pathology to molecular testing by extracting only the annotated tumor regions with unmatched precision.

Preserves diagnostic accuracy from slide to sequence, ensuring molecular data the desired target.

Reduces test failure by increasing the proportion of tissue of interest in low-content marginal samples

Accelerates decisions by minimizing non-tumor contamination to reduce noise and boost signal

Proven performance at Singapore General Hospital

Singapore General Hospital partners with QuantumCyte to improve the quality and reliability of molecular testing from solid tumor biopsies. In clinical studies, QCPRECISE™ enabled clearer results from low-content samples, increases variant detection sensitivity, and reduces test failure rates—helping SGH save lives by delivering fast and actionable diagnoses to patients.

Accelerating therapeutic development

Global pharmaceutical leaders are leveraging QCPRECISE™ to streamline biomarker discovery and accelerate the development of targeted therapies. By delivering high-purity, tumor-enriched samples at scale, QCPRECISE™ enables identification of actionable mutations, reduces trial timelines, and increases confidence in early-phase decisions—turning sample quality into clinical advantage.

QCPRECISE™ easily integrates into your lab workflow

1. Annotate your FFPE and H&E-stained solid-tissue samples as usual.

2. QCPRECISE™ automatically transfers annotations of Regions of Interest (ROI) to the test slides, automatically adjusting for changes between slides.